These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25855031)

  • 1. The biliary epithelium presents antigens to and activates natural killer T cells.
    Schrumpf E; Tan C; Karlsen TH; Sponheim J; Björkström NK; Sundnes O; Alfsnes K; Kaser A; Jefferson DM; Ueno Y; Eide TJ; Haraldsen G; Zeissig S; Exley MA; Blumberg RS; Melum E
    Hepatology; 2015 Oct; 62(4):1249-59. PubMed ID: 25855031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer T cells mediate inflammation in the bile ducts.
    Berntsen NL; Fosby B; Tan C; Reims HM; Ogaard J; Jiang X; Schrumpf E; Valestrand L; Karlsen TH; Line PD; Blumberg RS; Melum E
    Mucosal Immunol; 2018 Nov; 11(6):1582-1590. PubMed ID: 30115993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.
    Valestrand L; Berntsen NL; Zheng F; Schrumpf E; Hansen SH; Karlsen TH; Blumberg RS; Hov JR; Jiang X; Melum E
    Clin Exp Immunol; 2021 Feb; 203(2):304-314. PubMed ID: 33089489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
    Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
    Front Immunol; 2020; 11():610010. PubMed ID: 33312179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation.
    Schrumpf E; Jiang X; Zeissig S; Pollheimer MJ; Anmarkrud JA; Tan C; Exley MA; Karlsen TH; Blumberg RS; Melum E
    Physiol Rep; 2017 Feb; 5(4):. PubMed ID: 28219981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
    Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected].
    Muindi K; Cernadas M; Watts GF; Royle L; Neville DC; Dwek RA; Besra GS; Rudd PM; Butters TD; Brenner MB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3052-7. PubMed ID: 20133624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.
    Webb TJ; Bieler JG; Schneck JP; Oelke M
    J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
    Dasgupta S; Kumar V
    Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
    Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
    Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production.
    Omenetti A; Syn WK; Jung Y; Francis H; Porrello A; Witek RP; Choi SS; Yang L; Mayo MJ; Gershwin ME; Alpini G; Diehl AM
    Hepatology; 2009 Aug; 50(2):518-27. PubMed ID: 19575365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
    East JE; Sun W; Webb TJ
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice.
    Liu Y; Teige A; Mondoc E; Ibrahim S; Holmdahl R; Issazadeh-Navikas S
    J Clin Invest; 2011 Jan; 121(1):249-64. PubMed ID: 21157037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.
    Nishioka Y; Masuda S; Tomaru U; Ishizu A
    Front Immunol; 2018; 9():548. PubMed ID: 29599785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity.
    Rao P; Wen X; Lo JH; Kim S; Li X; Chen S; Feng X; Akbari O; Yuan W
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
    Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
    Maricic I; Girardi E; Zajonc DM; Kumar V
    J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.